Reflecting on the tragic loss of Matthew Perry, we discuss the critical importance of safe, ethical ketamine use. Explore our safety protocols and our response to the misuse highlighted by recent events.
Synthesized by Calvin Stevens, pushed through clinical trials by Domino and Corssen, and researched by more and more scientific and medical pioners: we explore prominent figures in ketamine’s development in the last 50+ years.
“Ketamine bladder” or “ketamine cystitis” is recognized by symptoms such as frequent urination, urgency, pain, and even bladder inflammation. Note: these problems are primarily linked to recreational use, where individuals consume ketamine in unregulated and excessive amounts.
As patients explore ketamine as a treatment option, they often encounter two primary methods of administration: intramuscular (IM) injections and intravenous (IV) infusions. Understanding the differences between these two methods can help patients make informed decisions about treatment.
Spravato, a nasal spray form of esketamine, is approved by the FDA for treatment-resistant depression, meaning it can be covered by insurance. We review its FDA approval, insurance coverage, and impact on mental health treatment.
Just a few years ago, ketamine was known mainly as an anesthetic and a party drug. Today, it’s prominent in headlines and specialized clinics nationwide. We explore the research, market trends, and the surge of ketamine clinics, examining why it’s increasingly accepted for treating depression and other mental health issues.
Research has highlighted ketamine’s anti-inflammatory properties, which could have significant implications for treating various inflammatory conditions. This blog explores how ketamine interacts with inflammatory cells and cytokines, and what these interactions mean biologically and physically, especially for chronic pain related conditions.
Integration is essential following ketamine therapy, both for efficacy and long-term success. Learn about the key components of effective integration and how it can enhance long-term outcomes for mental health treatment.
Psychedelic integration is the process of drawing insight from an often enigmatic experience. Learn how preparation and integration coaches support individuals before, during, and after psychedelic experiences, enhancing safety, meaning, and long-term benefits of these transformative journeys.
Learn about ketamine and esketamine’s molecular structures, FDA approvals, administration methods, and effectiveness in treating depression and other mental health conditions.
Reflecting on the tragic loss of Matthew Perry, we discuss the critical importance of safe, ethical ketamine use. Explore our safety protocols and our response to the misuse highlighted by recent events.
Synthesized by Calvin Stevens, pushed through clinical trials by Domino and Corssen, and researched by more and more scientific and medical pioners: we explore prominent figures in ketamine’s development in the last 50+ years.
“Ketamine bladder” or “ketamine cystitis” is recognized by symptoms such as frequent urination, urgency, pain, and even bladder inflammation. Note: these problems are primarily linked to recreational use, where individuals consume ketamine in unregulated and excessive amounts.
As patients explore ketamine as a treatment option, they often encounter two primary methods of administration: intramuscular (IM) injections and intravenous (IV) infusions. Understanding the differences between these two methods can help patients make informed decisions about treatment.
Spravato, a nasal spray form of esketamine, is approved by the FDA for treatment-resistant depression, meaning it can be covered by insurance. We review its FDA approval, insurance coverage, and impact on mental health treatment.
Just a few years ago, ketamine was known mainly as an anesthetic and a party drug. Today, it’s prominent in headlines and specialized clinics nationwide. We explore the research, market trends, and the surge of ketamine clinics, examining why it’s increasingly accepted for treating depression and other mental health issues.
Research has highlighted ketamine’s anti-inflammatory properties, which could have significant implications for treating various inflammatory conditions. This blog explores how ketamine interacts with inflammatory cells and cytokines, and what these interactions mean biologically and physically, especially for chronic pain related conditions.
Integration is essential following ketamine therapy, both for efficacy and long-term success. Learn about the key components of effective integration and how it can enhance long-term outcomes for mental health treatment.
Psychedelic integration is the process of drawing insight from an often enigmatic experience. Learn how preparation and integration coaches support individuals before, during, and after psychedelic experiences, enhancing safety, meaning, and long-term benefits of these transformative journeys.
Learn about ketamine and esketamine’s molecular structures, FDA approvals, administration methods, and effectiveness in treating depression and other mental health conditions.
